Integration of a postoperative calcitonin measurement into an anatomical staging system improves initial risk stratification in medullary thyroid cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2265|83|6|938-942

ISSN： 0300-0664

Source： CLINICAL ENDOCRINOLOGY, Vol.83, Iss.6, 2015-12, pp. : 938-942

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

No calcitonin change in a person taking dulaglutide diagnosed with pre‐existing medullary thyroid cancer

By  

DIABETIC MEDICINE, Vol. 35, Iss. 3, 2018-03 ,pp. : 381-385

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vandetanib for aggressive and symptomatic medullary thyroid cancer

By Deshpande Hari A   Carling Tobias   Khan Nabeela   Holt Elizabeth  

Clinical Practice, Vol. 10, Iss. 3, 2013-05 ,pp. : 275-282

Future Medicine

Access to resources Recommend Favorite

Medical management of metastatic medullary thyroid cancer

By  

CANCER, Vol. 120, Iss. 21, 2014-11 ,pp. : 3287-3301

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thyroid imaging reporting and data system score combined with Bethesda system for malignancy risk stratification in thyroid nodules with indeterminate results on cytology

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 3, 2015-03 ,pp. : 439-444

John Wiley & Sons Inc

Access to resources Recommend Favorite

A cut‐off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 4, 2015-04 ,pp. : 598-603

John Wiley & Sons Inc

Access to resources Recommend Favorite